2024 annual financial data
BioNexus Gene Lab 2024 Net margin
BioNexus Gene Lab 2024 net margin with verified reported values.
Direct answer
Net margin was -16.81%.
Operating income was -1,573,702 USD and net income was -1,598,342 USD.
Operating cash flow was -2,234,260 USD.
Get free BioNexus Gene Lab email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 9,510,646 USD
- Operating income
- -1,573,702 USD
- Net income
- -1,598,342 USD
- Operating cash flow
- -2,234,260 USD